Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Vallejos et al., BMC Infectious Diseases, doi:10.1186/s12879-021-06348-5
https://c19ivm.org/vallejos2.html